Edesa Biotech is trading at $3.66, down 6.03%, in pre-market, with no confirmed company-specific catalyst identified for the October 8, 2026 move. - The latest company news found predates the session; reported filings do not establish a new catalyst. - Broader markets are softer, but supplied index declines are below 0.5% and do not clearly explain the move. - Pre-market trading can be volatile; no volume or activity data was provided.